Naseem Zojwalla - 18 Mar 2024 Form 4 Insider Report for Olema Pharmaceuticals, Inc. (OLMA)

Role: CHIEF MEDICAL OFFICER
Signature: /s/ Shane Kovacs, Attorney-in-Fact
Issuer symbol: OLMA
Transactions as of: 18 Mar 2024
Net transactions value: +$66,719
Form type: 4
Filing time: 20 Mar 2024, 17:30:07 UTC
Previous filing: 05 Feb 2024
Next filing: 28 May 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OLMA	Common Stock	Options Exercise	$66,719	+13,700	+21%	$4.87^*	80,364	18 Mar 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OLMA	Stock Option (Right to Buy)	Options Exercise	$0	-13,700	-9.1%	$0.000000	136,300	18 Mar 2024	Common Stock	13,700	$4.87	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	25% of the shares subject to the option vested on February 1, 2024 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.